embecta to Report Fiscal Third Quarter 2025 Financial Results
Embecta (Nasdaq: EMBC), a medical supplies company specializing in insulin delivery, has scheduled its fiscal third quarter 2025 financial results conference call for August 8, 2025, at 8:00 a.m. ET. The company will present financial results, provide operational updates, and host a Q&A session.
Investors can access the presentation through a live webcast or teleconference. A replay will be available from 11:00 a.m. ET on the same day through the company's investor relations website, where it will remain archived for one year.
Embecta (Nasdaq: EMBC), azienda specializzata nella fornitura di dispositivi medici per la somministrazione di insulina, ha programmato la conference call per la presentazione dei risultati finanziari del terzo trimestre fiscale 2025 per il 8 agosto 2025 alle 8:00 ET. Durante l'incontro, la società illustrerà i risultati finanziari, fornirà aggiornamenti operativi e terrà una sessione di domande e risposte.
Gli investitori potranno seguire la presentazione tramite webcast in diretta o teleconferenza. La registrazione sarà disponibile in replica a partire dalle 11:00 ET dello stesso giorno sul sito web delle relazioni con gli investitori della società, dove resterà archiviata per un anno.
Embecta (Nasdaq: EMBC), una empresa de suministros médicos especializada en la administración de insulina, ha programado su conferencia telefónica para presentar los resultados financieros del tercer trimestre fiscal 2025 para el 8 de agosto de 2025 a las 8:00 a.m. ET. La compañía presentará los resultados financieros, ofrecerá actualizaciones operativas y realizará una sesión de preguntas y respuestas.
Los inversores podrán acceder a la presentación mediante una transmisión en vivo o teleconferencia. Una repetición estará disponible a partir de las 11:00 a.m. ET del mismo día en el sitio web de relaciones con inversores de la empresa, donde permanecerá archivada durante un año.
Embecta (나스닥: EMBC)는 인슐린 전달 전문 의료용품 회사로, 2025 회계연도 3분기 재무 실적 컨퍼런스 콜을 2025년 8월 8일 오전 8시(동부시간)에 개최할 예정입니다. 회사는 재무 실적을 발표하고 운영 현황을 업데이트하며 질의응답 시간을 가질 예정입니다.
투자자들은 라이브 웹캐스트 또는 전화 회의를 통해 발표에 참여할 수 있습니다. 녹화된 내용은 같은 날 오전 11시(동부시간)부터 회사 투자자 관계 웹사이트에서 재생 가능하며, 1년간 보관됩니다.
Embecta (Nasdaq : EMBC), une entreprise spécialisée dans les fournitures médicales pour l'administration d'insuline, a programmé sa conférence téléphonique sur les résultats financiers du troisième trimestre fiscal 2025 pour le 8 août 2025 à 8h00 ET. La société présentera ses résultats financiers, fournira des mises à jour opérationnelles et organisera une séance de questions-réponses.
Les investisseurs pourront suivre la présentation via un webinaire en direct ou une téléconférence. Une rediffusion sera disponible à partir de 11h00 ET le même jour sur le site des relations investisseurs de la société, où elle restera archivée pendant un an.
Embecta (Nasdaq: EMBC), ein Unternehmen für medizinische Versorgung mit Schwerpunkt auf Insulinabgabe, hat seine Telefonkonferenz zur Veröffentlichung der Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2025 für den 8. August 2025 um 8:00 Uhr ET angesetzt. Das Unternehmen wird die Finanzergebnisse vorstellen, betriebliche Updates geben und eine Fragerunde abhalten.
Investoren können die Präsentation per Live-Webcast oder Telefonkonferenz verfolgen. Eine Aufzeichnung wird ab 11:00 Uhr ET am selben Tag auf der Investor-Relations-Website des Unternehmens verfügbar sein und dort für ein Jahr archiviert bleiben.
- None.
- None.
PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal third quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, August 8, 2025.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on August 8, 2025, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When is Embecta (EMBC) reporting its Q3 2025 earnings?
How can investors access Embecta's Q3 2025 earnings call?
How long will Embecta's Q3 2025 earnings call replay be available?
What will be discussed during Embecta's Q3 2025 earnings call?
